Libya vs Sierra Leone: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Libya
92.0%
in 2025
Sierra Leone
93.0%
in 2025
Libya rank
56th
Sierra Leone rank
53rd
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Libya
- Sierra Leone
How they compare
Sierra Leone currently reports 93.0% against 92.0% in Libya, a difference of 1.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Sierra Leone ahead.
Libya ranks 56th and Sierra Leone ranks 53rd of 194 countries.
Sierra Leone has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 44.6% | 78.8% | 34.2% | Sierra Leone |
| 2020s | 78.8% | 92.2% | 13.3% | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Libya or Sierra Leone?
- Sierra Leone, at 93.0% against 92.0% in Libya as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Libya and Sierra Leone?
- 1.0%, with Sierra Leone ahead.
- How many years of comparable data are there for Libya and Sierra Leone?
- 18 years are reported by both, from 2008 to 2025.
- How do Libya and Sierra Leone rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Libya ranks 56th and Sierra Leone ranks 53rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.